Trastuzumab Has Radically Improved Prognosis for HER2+ Breast

Trastuzumab emtansine binds to the HER2 receptor's sub-domain IV and goes into the cell by receptor-mediated endocytosis Lysosomes degrade trastuzumab

The story of trastuzumab begins with Axel Ullrich's dedication to the concept that receptor tyrosine kinases must be the key to many human

trastuzumab Trastuzumab emtansine binds to the HER2 receptor's sub-domain IV and goes into the cell by receptor-mediated endocytosis Lysosomes degrade trastuzumab

trastuzumab Possible Side Effects of Trastuzumab · Heart Problems · Infusion-Related Side Effects · Lung Problems · Low White Blood Cell Count (Leukopenia